⌘K

Login Start Free

Home/Filings/4/0001171843-12-002326

4//SEC Filing

DiCorleto Paul E 4

Accession 0001171843-12-002326

CIK 0001318641other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 9:24 PM ET

Size

4.9 KB

Accession

0001171843-12-002326

Insider Transaction Report

Form 4

Period: 2012-06-13

CLEVELAND BIOLABS INCCBLI

DiCorleto Paul E

Director

Transactions

Award
Stock Options (Right to Buy)
2012-06-13+35,000→ 35,000 total
Exercise: $1.79From: 2012-06-13Exp: 2022-06-12→ Common Stock (35,000 underlying)

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1

filerCIK 0001370082

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 9:24 PM ET
Size: 4.9 KB

View on SEC.gov